
|Articles|October 1, 2003
Supplements and Featured Publications
- Biopharmaceutical Agents for Treating Rheumatoid Arthritis: Impact on Patients and Managed Care Heal
- Volume 9
- Issue 6 Suppl
Treatment Compliance and Dosage Administration Among Rheumatoid Arthritis Patients Receiving Infliximab, Etanercept, or Methotrexate
Advertisement
Articles in this issue
over 22 years ago
Participating FacultyNewsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
NYC Nurses Strike Enters Day 5 Amid Staffing, Safety, and Benefit Disputes
2
Respiratory Vaccination by the Numbers: COVID-19, Flu, and RSV
3
Anti-Inflammatory, Antioxidant-Rich Diets May Lower Skin Cancer Risk, Slow Biological Aging
4
Value-Based Care Needs a Rebrand. Will 2026 Be the Year It Finally Gets One?
5




























































